Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04839991
Title Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours. (POTENTIA)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Crescendo Biologics Ltd.
Indications

castration-resistant prostate carcinoma

prostate cancer

Advanced Solid Tumor

Therapies

CB307

Age Groups: adult | senior
Covered Countries


No variant requirements are available.